PTGX EBITDA Growth
Protagonist Therapeutics Inc · EBITDA Growth
PTGX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported54.72%period ending
PTGX TTM EBITDA YoY % (-122.38% → 54.72%)
Year-over-year change
High-resolution chart · PNG
PTGX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 54.7202% | |
| -289.9258% | |
| -145.3523% | |
| -71.9118% | |
| -68.458% | |
| -64.3269% | |
| 473.2044% | |
| 230.0828% | |
| 232.7042% | |
| 224.4077% | |
| 38.183% | |
| -6.1477% | |
| -1.7089% | |
| -12.2617% | |
| 1.0776% | |
| -21.6845% | |
| -65.1308% | |
| -81.9293% | |
| -100.2185% | |
| -81.287% | |
| -18.56% | |
| 16.5881% | |
| 16.138% | |
| 22.5003% | |
| 2.118% | |
| -69.0891% | |
| -76.4913% | |
| -150.1172% | |
| -166.9335% | |
| -49.1623% | |
| -11.3387% | |
| 34.2669% | |
| 46.4538% | |
| 20.4969% | |
| -15.8954% | |
| -75.0781% | |
| -108.2422% | |
| -109.5377% | |
| -122.3757% |